logo

For the Inventor, By the Inventor

Plainsboro, NJ, United States of America

Ivo L Jirkovsky

This inventor holds 28 USPTO granted patents, primarily in Piperazine Synthesis. Top assignees: American Home Products Corporation, Wyeth, Wyeth Holdings Corporation. Active years: 1986-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ivo L Jirkovsky. Retrieved from https://idiyas.com/inventor/ivo-l-jirkovsky-eng3eeez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 28

% Patents Active = 71.4

Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 102(Granted Patents)


Location History:

  • Plainsboro, NJ (US) (1986 - 1995)
  • Nanuet, NY (US) (1999 - 2004)
  • Waitsfield, VT (US) (2004 - 2008)

Company Filing History:

goldMedal20 out of 1,567 
 
American Home Products Corporation
 patents
silverMedal7 out of 1,309 
 
Wyeth
 patents
bronzeMedal1 out of 113 
 
Wyeth Holdings Corporation
 patents

Years Active: 1986-2008

Loading Chart...
Areas of Expertise:
Piperazine
Beta-Lactamase
Chiral Compounds
Biologically Active
Heterocyclic
Sulfonyl
Furanones
Indole Derivatives
Phosphono-Amino Acids
Bone Loss Inhibition
Anti-Ulcer
Synthesis Process
28 patents (USPTO):Explore Patents
1. 7361773 - Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines (2008-04-22),
2. 7276611 - Process for synthesizing beta-lactamase inhibitor intermediates (2007-10-02),
3. 7256289 - Process for making chiral 1,4-disubstituted piperazines (2007-08-14),
4. 7091349 - Process for synthesizing N-aryl piperazines with chiral N'-1-[benzoyl(2-pyridyl)amino]-2-propane substitution (2006-08-15),
5. 7019137 - Process for making chiral 1,4-disubstituted piperazines (2006-03-28),
6. 6784294 - Preparation of N1-(2′-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines (2004-08-31),
7. 6743796 - Piperazinyl-isatins (2004-06-01),
8. 6713626 - Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution (2004-03-30),
9. 6355630 - Estra-1,3,5(10)-triene-7&agr;-thioethers (2002-03-12),
10. 5952506 - Process for the synthesis of 4-�6- (hexylcarbamoyloxy) (1999-09-14),
11. 5438056 - Heterocyclic oxime carbamates (1995-08-01),
12. 5389673 - 4- or 5-(substituted sulfonyl)methyl-3(2H)-furanones (1995-02-14),
13. 5389672 - 4- or 5-(substituted sulfonyl)methyl-3(2H)-furanones (1995-02-14),
14. 5389671 - 4- or 5-(substituted sulfonyl)methyl-3(2H)-furanones (1995-02-14),
15. 5314913 - 4- or 5-(substituted sulfonyl)methyl-3(2H)-furanones (1994-05-24),

Title: **Ivo L Jirkovsky: Innovator in Pharmaceutical Chemistry**

Introduction

Ivo L Jirkovsky is a notable inventor residing in Plainsboro, NJ, known for his significant contributions to pharmaceutical chemistry. With an impressive portfolio of 28 patents, he has made strides in the synthesis of biologically active compounds, paving the way for advancements in medicine.

Latest Patents

Among his latest innovations are several patents that highlight his expertise in chemical synthesis. One notable patent is for the preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its application in creating biologically active piperazines. Additionally, he has developed a process for making a compound that involves dialkylating a benzodioxane aniline. His work on synthesizing beta-lactamase inhibitor intermediates stands out, offering a process to prepare bicyclic heteroaryl carboxaldehydes, which serve as essential intermediates in producing β-lactamase inhibitors.

Career Highlights

Throughout his career, Ivo has worked with reputable organizations like American Home Products Corporation and Wyeth. His tenure at these companies has contributed to his extensive experience in the field of pharmaceutical development and innovation.

Collaborations

Ivo has had the privilege of collaborating with esteemed colleagues such as Steven W Felman and Kevin Anthony Memoli. These collaborations highlight his ability to work within a team, fostering innovation and pushing the boundaries of pharmaceutical research.

Conclusion

Ivo L Jirkovsky's work demonstrates a profound commitment to advancing pharmaceutical chemistry. His numerous patents and collaborations signify a legacy of innovation that continues to influence the industry. With a strong foundation in research and development, he remains a vital figure in the realm of drug synthesis and invention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…